Lidocaine
SIGMA/L7757 - powder
Synonym: 2-Diethylamino-N-
CAS Number: 137-58-6
Empirical Formula (Hill Notation): C14H22N2O
Molecular Weight: 234.34
EC Number: 205-302-8
MDL Number: MFCD00026733
Linear Formula: C14H22N2O
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: L7757-100G
| form | powder |
| InChI | 1S/C14H22N2O/c1-5-16(6-2) |
| InChI key | NNJVILVZKWQKPM-UHFFFAOYSA |
| Quality Level | 100  |
| SMILES string | CCN(CC)CC(=O)Nc1c(C)cccc1 |
| Application: | Lidocaine may be used for drug testing and for voltage clamp experiments. |
| Biochem/physiol Actions: | Lidocaine, a neuroprotective agent, mediates blockage of sodium (Na+) channels. It prevents the influx of sodium ions leading to depolarization of sodium channels and metabolically inactivated in liver. Lidocaine has positive effect on cerebral ischemia. It is also used in the treatment of ventricular tachycardia. Lidocaine is an efficient anesthetic agent in ophthalmic surgeries as it is highly potent and has good tissue penetrability. |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration. |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic. |
| General description: | Lidocaine is a local anesthetic and an effective antiarrhythmia agent. It occurs as solutions of crystalline colorless solid for injections, that has a short half-life within plasma. |
| Packaging: | 25, 100 g in poly bottle |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 22-26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |